Paul Ehrlich, an evolutionary biologist and ecologist at Stanford.

斯坦福大的进化生物家和生态家保罗·埃利希说到。

The article by Ehrlich, colleagues and scientist signatories is in the journal BioScience.

这篇由埃利希和同事以及科家签署的文章发表在《生物科》期刊上。

In October 1990, Julian Simon received a check from Paul Ehrlich.

1990 10 ，Julian Simon 收到了 Paul Ehrlich 的支票。

During our research for this show, we spoke to Ehrlich online.

在我们为这个节目做研究的过程中， 我们在线采访了埃利希。

1907. Paul Ehrlich discovers arsphenamine, which is later released as salvarsan, the first synthetic antimicrobial.

1907. 保罗·埃尔利希发了砷凡纳明，后来以撒尔万胂的形式发布，这是第一种成的抗菌药物。

Hi, everyone, I'm Rosemary Miller here with Stephen Ehrlich, the Director of Forbes Digital Assets.

大家好，我是Rosemary Miller，今天和我一起的是福布斯数字资产总监Stephen Ehrlich。

I particularly liked watching Ehrlich Bachman and Jin Yang fighting.

我特别喜欢看埃里希·巴赫曼和金·杨的对决。

If the price increased, Ehrlich won.

如果价格上涨，埃利希赢了。

Ehrlich aimed to find a cure for the sexually transmitted disease syphilis.

埃尔利希致力于寻找一种治疗性传播疾病梅毒的方法。

I'm Rosemary Miller here with Stephen Ehrlich, the Director of Forbes Digital Assets, here to tell us more.

我是罗丝玛丽·米勒，这里与我一起的是福布斯数字资产总监史蒂芬·埃hr利希，他将为我们带来更多详情。

A group led by Professor Ehrlich took the bet and chose five natural resources.

埃利希教授领导的一个小组接受了赌注，选择了五种自然资源。

Betting against Ehrlich was Julian Simon, a professor of business and economics.

与埃利希作对的是商业和经济教授朱利安·西蒙 (Julian Simon)。

Ehrlich marketed it as the drug Salvarsan in 1910.

埃尔利希于1910将此药推向市场，命名为“洒尔佛散”（Salvarsan）。

Ehrlich and other experts found Simon's claims preposterous.

埃利希和其他专家认为西蒙的说法很荒谬。

In 1912, Ehrlich introduced the improved version, neo-salvarsan, which then became the standard treatment for syphilis.

1912，埃尔利希推出了改进版药物——新胂凡纳明，这一药物随即成为治疗梅毒的标准疗法。

That was Paul Ehrlich, who wrote the book Population Bomb, and clips of him saying that are in the documentary.

那是保罗·埃利希，他写了《人口炸弹》一书，纪录片中也收录了他的一些言论片段。

Ehrlich believed a growing population would consume such finite resources, and scarcity would drive the prices up.

埃利希认为，不断增长的人口会消耗如此有限的资源，而稀缺性会推高价格。

Ehrlich decided to make this bacterium his first target.

埃hrlich决定将这种细菌作为他的第一个目标。

It was clear to Ehrlich that there was some connection between the chemical structure of the dyes and living cells.

埃尔利希清楚地认识到，染料的化结构与活细胞之间存在某种联系。

In 1912 Ehrlich's laboratory developed a less toxic version, Neo-Salvarsan.

1912，埃尔利希的实验室研发出毒性较低的版本——新胂凡纳明。